FRED MEDS Trademark

Trademark Overview


On Wednesday, May 29, 2024, a trademark application was filed for FRED MEDS with the United States Patent and Trademark Office. The USPTO has given the FRED MEDS trademark a serial number of 98573253. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, December 20, 2024. This trademark is owned by FRED MEDS INC.. The FRED MEDS trademark is filed in the Advertising, Business and Retail Services category with the following description:

Online retail store services featuring nutritional and dietary supplements; online retail store services featuring products in the field of weight loss
fred meds

General Information


Serial Number98573253
Word MarkFRED MEDS
Filing DateWednesday, May 29, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, December 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesOnline retail store services featuring nutritional and dietary supplements; online retail store services featuring products in the field of weight loss
NOT AVAILABLE"MEDS"

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, May 29, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameFRED MEDS INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCorona del Mar, CA 92625

Trademark Events


Event DateEvent Description
Wednesday, May 29, 2024NEW APPLICATION ENTERED
Thursday, December 5, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 11, 2024ASSIGNED TO EXAMINER
Friday, December 20, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 20, 2024NON-FINAL ACTION E-MAILED
Friday, December 20, 2024NON-FINAL ACTION WRITTEN